{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:10:49Z","timestamp":1787793049714,"version":"build-2784847793"},"reference-count":37,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.3892\/mmr.2015.3814","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T11:22:48Z","timestamp":1432207368000},"page":"3639-3647","source":"Crossref","is-referenced-by-count":16,"title":["Pirfenidone attenuates bladder fibrosis and mitigates deterioration of bladder function in a rat model of partial bladder outlet obstruction"],"prefix":"10.3892","volume":"12","author":[{"given":"LIU JIAN","family":"DUAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JUN","family":"QI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAO","family":"HUANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIN","family":"GU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DING","family":"XU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIANG JIE","family":"KONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIAO QIANG","family":"QIAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,5,21]]},"reference":[{"key":"key20180108020215_b1-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/j.1464-410X.2010.09445.x","article-title":"Bladder outlet obstruction: progression from inflammation to fibrosis","volume":"106","author":"Metcalfe","year":"2010","journal-title":"Bju Int"},{"key":"key20180108020215_b2-mmr-12-03-3639","first-page":"157","article-title":"Growth factors and receptors in bladder development and obstruction","volume":"75","author":"Baskin","year":"1996","journal-title":"Lab Invest"},{"key":"key20180108020215_b3-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/(SICI)1520-6777(2000)19:1<29::AID-NAU5>3.0.CO;2-#","article-title":"Effects of partial bladder outlet obstruction and its relief on types I and III collagen and detrusor contractility in the rat","volume":"19","author":"Kim","year":"2000","journal-title":"Neurourol Urodyn"},{"key":"key20180108020215_b4-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/S0022-5347(01)64782-7","article-title":"Type III collagen messenger RNA is modulated in non-compliant human bladder tissue","volume":"157","author":"Kaplan","year":"1997","journal-title":"J Urol"},{"key":"key20180108020215_b5-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.it.2009.12.001","article-title":"The immunology of fibrosis: innate and adaptive responses","volume":"31","author":"Wick","year":"2010","journal-title":"Trends Immunol"},{"key":"key20180108020215_b6-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/01902149809046058","article-title":"Lung fibrosis is ameliorated by pirfenidone fed in diet after the second dose in a three-dose bleomycin-hamster model","volume":"24","author":"Iyer","year":"1998","journal-title":"Exp Lung Res"},{"key":"key20180108020215_b7-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0378-4274(96)03845-3","article-title":"Pirfenidone diminishes cyclophosphamide-induced lung fibrosis in mice","volume":"90","author":"Kehrer","year":"1997","journal-title":"Toxicol Lett"},{"key":"key20180108020215_b8-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1164\/rccm.200404-571OC","article-title":"Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"171","author":"Azuma","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"key20180108020215_b9-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2011.12.025","article-title":"Pirfenidone restricts Th2 differentiation in vitro and limits Th2 response in experimental liver fibrosis","volume":"678","author":"Navarro-Partida","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"key20180108020215_b10-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0168-8278(02)00272-6","article-title":"Pirfenidone effectively reverses experimental liver fibrosis","volume":"37","author":"Garc\u00eda","year":"2002","journal-title":"J Hepatol"},{"key":"key20180108020215_b11-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"F676","DOI":"10.1152\/ajprenal.00507.2012","article-title":"Pirfenidone inhibits macrophage infiltration in 5\/6 nephrectomized rats","volume":"304","author":"Chen","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"key20180108020215_b12-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"e28134","DOI":"10.1371\/journal.pone.0028134","article-title":"In vitro effects of pirfenidone on cardiac fibroblasts: Proliferation, myofibroblast differentiation, migration and cytokine secretion","volume":"6","author":"Shi","year":"2011","journal-title":"PLoS One"},{"key":"key20180108020215_b13-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/SAP.0b013e31821b6d08","article-title":"A controlled clinical trial with pirfenidone in the treatment of pathological skin scarring caused by burns in pediatric patients","volume":"68","author":"Armaendariz-Borunda","year":"2012","journal-title":"Ann Plast Surg"},{"key":"key20180108020215_b14-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1440-1681.2009.05194.x","article-title":"Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells","volume":"36","author":"Zhao","year":"2009","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"key20180108020215_b15-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0022-3565(24)35110-9","article-title":"Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis","volume":"291","author":"Iyer","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"key20180108020215_b16-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.urology.2008.10.032","article-title":"Protective effects of inosine on urinary bladder function in rats with partial bladder outlet obstruction","volume":"73","author":"Liu","year":"2009","journal-title":"Urology"},{"key":"key20180108020215_b17-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/j.juro.2012.12.101","article-title":"Effects of coenzyme Q10 on bladder dysfunction induced by chronic bladder ischemia in a rat model","volume":"189","author":"Kim","year":"2013","journal-title":"J Urol"},{"key":"key20180108020215_b18-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejphar.2008.06.046","article-title":"Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis","volume":"590","author":"Oku","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"key20180108020215_b19-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.juro.2009.05.004","article-title":"Assessing the effects of transforming growth factor-beta1 on bladder smooth muscle cell phenotype. II Modulation of collagen organization","volume":"182","author":"Parekh","year":"2009","journal-title":"J Urol"},{"key":"key20180108020215_b20-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1464-410X.1981.tb03151.x","article-title":"Elastin and collagen in the normal and obstructed urinary bladder","volume":"53","author":"Cortivo","year":"1981","journal-title":"Br J Urol"},{"key":"key20180108020215_b21-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0022-5347(17)36650-8","article-title":"Is lamina propria matrix responsible for normal bladder compliance?","volume":"148","author":"Ewalt","year":"1992","journal-title":"J Urol"},{"key":"key20180108020215_b22-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0022-5347(01)62375-9","article-title":"Decreased elastin gene expression in noncompliant human bladder tissue: a competitive reverse transcriptase-polymerase chain reaction analysis","volume":"160","author":"Djavan","year":"1998","journal-title":"J Urol"},{"key":"key20180108020215_b23-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1007\/s10439-008-9525-9","article-title":"The effects of long-term spinal cord injury on mechanical properties of the rat urinary bladder","volume":"36","author":"Toosi","year":"2008","journal-title":"Ann Biomed Eng"},{"key":"key20180108020215_b24-mmr-12-03-3639","first-page":"311","article-title":"Extracellular signal-regulated kinase activation in airway smooth muscle cell proliferation in chronic asthmatic rats","volume":"59","author":"Bai","year":"2007","journal-title":"Sheng Li Xue Bao"},{"key":"key20180108020215_b25-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"H2927","DOI":"10.1152\/ajpheart.00700.2006","article-title":"Endogenous interleukin-1 alpha promotes a proliferative and proinflammatory phenotype in human vascular smooth muscle cells","volume":"292","author":"Schultz","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key20180108020215_b26-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.cellsig.2006.05.009","article-title":"TGF-beta receptor-binding proteins: complex interactions","volume":"18","author":"Runyan","year":"2006","journal-title":"Cell Signal"},{"key":"key20180108020215_b27-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","article-title":"TGF-beta signaling and the fibrotic response","volume":"18","author":"Leask","year":"2004","journal-title":"FASEB J"},{"key":"key20180108020215_b28-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.urology.2005.06.124","article-title":"Transforming growth factor-beta1-induced hypertrophy and matrix expression in human bladder smooth muscle cells","volume":"66","author":"Howard","year":"2005","journal-title":"Urology"},{"key":"key20180108020215_b29-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1124\/jpet.106.119115","article-title":"Role of transforming growth factor beta in rat bladder smooth muscle cell proliferation","volume":"322","author":"Barendrecht","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"key20180108020215_b30-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1183\/09059180.00001111","article-title":"Antifibrotic activities of pirfenidone in animal models","volume":"20","author":"Schaefer","year":"2011","journal-title":"Eur Respir Rev"},{"key":"key20180108020215_b31-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejphar.2008.06.110","article-title":"Potent antioxidant role of pirfenidone in experimental cirrhosis","volume":"595","author":"Salazar-Montes","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"key20180108020215_b32-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0014-2999(02)01757-0","article-title":"Pirfenidone suppresses tumor necrosis factor-alpha, enhances interleukin-10 and protects mice from endotoxic shock","volume":"446","author":"Oku","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"key20180108020215_b33-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1440-1681.2001.03481.x","article-title":"Pirfenidone inhibits dimethylnitrosamine-induced hepatic fibrosis in rats","volume":"28","author":"Tada","year":"2001","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"key20180108020215_b34-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1748-717X-2-19","article-title":"Oral pirfenidone in patients with chronic fibrosis resulting from radiotherapy: a pilot study","volume":"2","author":"Simone","year":"2007","journal-title":"Radiat Oncol"},{"key":"key20180108020215_b35-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1191\/1352458505ms1134oa","article-title":"A double-blind, randomized, controlled study of oral pirfenidone for treatment of secondary progressive multiple sclerosis","volume":"11","author":"Walker","year":"2005","journal-title":"Mult Scler"},{"key":"key20180108020215_b36-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1016\/j.fct.2012.05.049","article-title":"Genotoxic evaluation of pirfenidone using erythrocyte rodent micronucleus assay","volume":"50","author":"Alc\u00e1ntar-D\u00edaz","year":"2012","journal-title":"Food Chem Toxicol"},{"key":"key20180108020215_b37-mmr-12-03-3639","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0022-5347(05)67204-7","article-title":"Cystometric evaluation of bladder function in non-anesthetized mice with and without bladder outlet obstruction","volume":"164","author":"Pandita","year":"2000","journal-title":"J Urol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2015.3814\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T01:57:06Z","timestamp":1748397426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2015.3814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,21]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,5,21]]},"published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.3892\/mmr.2015.3814"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2015.3814","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,21]]}}}